Liang X, Bi S, Yang W et al (2009) Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 27(47):6550–6557
Brunt EM, Wong VW, Nobili V et al (2015) Nonalcoholic fatty liver disease. Nat. Rev. Dis. Primers 1:150–803
Article
Google Scholar
De Minicis S, Day C, Svegliati-Baroni G et al (2013) From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights. Curr Pharm Des. 19:5239–5249
Azzam H, Malnick S (2015) Non-alcoholic fatty liver disease—the heart of the matter. World J Hepatol 7(10):1369–1376
Article
PubMed
PubMed Central
Google Scholar
Targher G, Bertolini L, Rodella S et al (2008) Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 51:444–450
Article
CAS
PubMed
Google Scholar
Schwimmer JB, Deutsch R, Kahen T et al (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388–1393
Article
PubMed
Google Scholar
Machado MV, Oliveira AG, Cortez-Pinto H et al (2011) Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J. Gastroenterol. Hepatol 26:1361–1367
PubMed
Google Scholar
Chan AW, Wong GL, Chan HY et al (2017) Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. J. Gastroenterol. Hepatol 32(3):667–676
Article
CAS
PubMed
Google Scholar
Nagy LE (2003) Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp. Biol. Med 228:882–890
Article
CAS
Google Scholar
Maher JJ, Leon P, Ryan JC et al (2008) Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatol 48:670–678
Article
CAS
Google Scholar
Zhang Z, Pan Q, Duan XY et al (2012) Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model. J. Gastroenterol. Hepatol 27:1858–1864
Article
CAS
PubMed
Google Scholar
Bjorkbacka H, Kunjathoor VV, Moore KJ et al (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med 10(4):416–421
Article
PubMed
CAS
Google Scholar
Ali BA, Salem HH, Wang XM et al (2009) Detection of hepatitis B polymerase gene in early embryonic cells from golden hamster oocyte and human spermatozoa carrying HBV DNA. Int. J. Virol 5(4):164–169
Article
CAS
Google Scholar
Tsuge M, Hiraga N, Akiyama R et al (2010) HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. J. Gen. Virol 91:1854–1864
Article
CAS
PubMed
Google Scholar
Ali BA (2015) Hepatitis B Virus (HBV) and Its Vertical Transmission. LAP Lambert Academic Publishing, Germany, Editor, ISBN: 978-3-659-71140-4.
Seeger C, Zoulim F, Mason WS et al (2014) Hepadnaviruses. In: Knipe DM, Howley PM (eds) Field’s Virology, 6th edn. Wolters Kluwer/Lippincott Williams & Wilkins Health, Philadelphia, PA, pp 3376–3436
Nassal M (2015) HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 64:1972–1984
Article
CAS
PubMed
Google Scholar
Seeger C, Mason WS (2015) Molecular biology of hepatitis B virus infection. Virol 479(480C):672–686
Article
CAS
Google Scholar
Schaefer S (2007) Hepatitis B virus genotypes in Europe. Hepatol Res 37:S20–S26
Article
CAS
PubMed
Google Scholar
Tatematsu K, Tanaka Y, Kurbanov F et al (2009) A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. Virol 83:10538–10547
Kramvis A (2014) Genotypes and genetic variability of hepatitis B virus. Intervirol 57:141–150
Article
Google Scholar
Raimondo G, Allain JP, Brunetto MR et al (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. Hepatol 49:652–657
Article
Google Scholar
Torbenson M, Thomas DL (2002) Occult hepatitis B. Lancet Infect. Dis 2:479–486
Article
PubMed
Google Scholar
Muhlemann B, Jones TC, Damgaard PDB et al (2018) Ancient hepatitis B viruses from the bronze age to the medieval period. Nature 557:418–423
Article
CAS
PubMed
Google Scholar
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in Globocan 2012. Int J Cancer 136:E359–E386
Article
CAS
PubMed
Google Scholar
El-Serag HB (2012) Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma. Gastroenterol 142:1264–1273 e1261
Article
Google Scholar
WHO? Global Health Estimates. (2015). Estimated Deaths by Cause, 2000 and 2015. Available online: http://www.who.int/entity/healthinfo/global_burden_disease/GHE2015_Deaths_Global_2000_2015.xls. (Accessed on 10 April 2017).
World Health Organization (2017) Global Hepatitis Report. WHO, Geneva, p 2017
Google Scholar
Centers for Disease Control and Prevention. (2017). Preventing hepatitis B. https://www.cdc.gov/globalhealth/immunization/othervpds/preventing_hepatitisb.html. Retrieved March 30, 2018.
Vanni E, Marengo A, Mezzabotta L et al (2015) Systemic complications of nonalcoholic fatty liver disease: when the liver is not an innocent bystander. Semin Liver Dis 35:236–249
Article
PubMed
Google Scholar
Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7:195–203
Article
PubMed
Google Scholar
Vernon G, Baranovam A, Younossim ZM et al (2011) Systematic review: the epidemiology and natural history of non- alcoholic fatty liver disease and non- alcoholic steatohepatitis in adults. Aliment Pharm Ther 34:274–285
Article
CAS
Google Scholar
Musso G, Gambino R, Cassader M et al (2011) Meta- analysis: natural history of non- alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non- invasive tests for liver disease severity. Annu. Rev.Med 43:617–649
Article
Google Scholar
Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non- alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatol 55:2005–2023
Article
Google Scholar
Adams LA, Lymp JF, St-Sauver J et al (2005) The natural history of nonalcoholic fatty liver disease: a population- based cohort study. Gastroenterol 129:113–121
Article
Google Scholar
Bhala N, Angulo P, Van-der Poorten D et al (2011) The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatol (Baltimore, MD) 54:1208–1216
Article
Google Scholar
Younossi ZM (2016) Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol 64:73–84
Article
Google Scholar
Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690
Article
CAS
PubMed
Google Scholar
European Association of Study Liver, European Association of Study Diabetes, European Association of Study Obstetrics (2016) EASL-EASDEASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Hepatol 64:1388–1402
Google Scholar
Satapathy SK, Sanyal AJ (2015) Epidemiology and natural history of nonalcoholic fatty liver disease. Sem Liver Dis 35:221–235
Article
Google Scholar
Angulo P, Kleiner DE, Dam-Larsen S et al (2015) Liver fibrosis, but no other histological features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterol 149:389–397
Article
Google Scholar
Caussy C (2017) Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis. J clin invest 127:2697–2704
Loomba R (2015) Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterol 149:1784–1793
Article
Google Scholar
Pouladi N, Bime C, Garcia JGN et al (2016) Complex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencing. Transl Res 168:22–39
Article
CAS
PubMed
Google Scholar
Huang PL (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2:231–237
Article
CAS
PubMed
PubMed Central
Google Scholar
Käräjämäki AJ (2017) Non-alcoholic fatty liver disease with and without metabolic syndrome: different long-term outcomes. Metabolism 66:55–63
Article
PubMed
CAS
Google Scholar
Allen AM (2018) Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study. Hepatol 67:1726–1736
Article
CAS
Google Scholar
Bazick J, Donithan M, Neuschwander-Tetri B et al (2015) Clinical model for NASH and advanced fibrosis in adult patients with diabetes and NAFLD: guidelines for referral in NAFLD. Diabetes Care 38:1347–1355
Article
PubMed
PubMed Central
Google Scholar
Kwok R (2016) Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut 65:1359–1368
Article
CAS
PubMed
Google Scholar
Anstee QM, Targher G, Day CP et al (2013) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10:330–344
Article
CAS
PubMed
Google Scholar
Choudhury J, Sanyal AJ (2008) Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liv Dis 8:575–594
Article
Google Scholar
Ballestri S (2016) Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J. Gastroenterol. Hepatol 31:936–944
Article
CAS
PubMed
Google Scholar
Ballestri S (2016) Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis J Gastroenterol Hepatol. 2016;31(5):936-44. https://doi.org/10.1111/jgh.13264. PMID:26667191
Neuschwander-Tetri BA (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatol 52:774–788
Article
CAS
Google Scholar
Banini BA, Sanyal AJ (2016) Nonalcoholic fatty liver disease: epidemiology, pathogenesis, natural history, diagnosis, and current treatment options. Clin Med Ins Ther 8:75–84
CAS
Google Scholar
Usluer G, Erben N, Aykin N et al (2012) Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C. Eur J Clin Microl 31:1873–1878
Article
CAS
Google Scholar
Arora A, Sharma P (2012) Non-invasive diagnosis of fibrosis in non-alcoholic fatty liver disease. Clin Exp Hepatol 2:145–155
Article
Google Scholar
De Gottardi AM, Vinciguerra A, Sgroi M et al (2007) Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes. Lab Invest 87:792–806
Article
PubMed
CAS
Google Scholar
Ricchi MMR, Odoardi L, Carulli C et al (2009) Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J. Gastroenterol. Hepatol 24:830–840
Article
CAS
PubMed
Google Scholar
Currie EA, Schulze R, Zechner TC et al (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18:153–161
Article
CAS
PubMed
PubMed Central
Google Scholar
Cantor JR, Sabatini DM (2012) Cancer cell metabolism: one hallmark, many faces. Cancer Discov 2:881–898
Article
CAS
PubMed
PubMed Central
Google Scholar
Godoy P, Hewitt NJ, Albrecht U et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and nonparenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Ach. Toxicol 87:1315–1530
Article
CAS
Google Scholar
Elaut G, Henkens T, Papeleu P et al (2006) Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr. Drug. Metab 7:629–660
Article
CAS
PubMed
Google Scholar
Hu C, Li L (2015) In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration. Protein Cell 6:562–574
Article
CAS
PubMed
PubMed Central
Google Scholar
Holmgren G, Sjögren AK, Barragan I et al (2014) Long-term chronic toxicity testing using human pluripotent stem cellderived hepatocytes. Drug Metab Dispos 42:1401–1406
Article
PubMed
CAS
Google Scholar
Medine CN, Lucendo-Villarin B, Storck C et al (2013) Developing high-fidelity hepatotoxicity models from pluripotent stem cells. Stem Cells Transl Med 2:505–509
Article
CAS
PubMed
PubMed Central
Google Scholar
Szkolnicka D, Farnworth SL, Lucendo-Villarin B et al (2014) Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med 3:141–148
Article
CAS
PubMed
Google Scholar
Lucendo-Villarin B, Filis P, Swortwood MJ et al (2017) Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells. Ach Toxicol 91:1–11
Google Scholar
Szkolnicka D, Lucendo-Villarin B, Moore JK et al (2016) Reducing hepatocyte injury and necrosis in response to paracetamol using noncoding RNAs. Stem Cells Transl Med 5:764–772
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang D, Yuan Q, Balakrishnan A et al (2016) MicroRNA-125b-5p mimic inhibits acute liver failure. Nat. Commun 7:11916
Article
CAS
PubMed
PubMed Central
Google Scholar
Leung A, Nah SK, Reid W et al (2013) Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. Stem Cell Rep 1:451–463
Article
CAS
Google Scholar
Zhou X, Sun P, Lucendo-Villarin B et al (2014) Modulating innate immunity improves hepatitis C virus infection and replication in stem cell derived hepatocytes. Stem Cell Rep 3:204–214
Article
CAS
Google Scholar
Wang CC, Tseng TC, Kao JH (2015) Hepatitis B virus infection and metabolic syndrome: fact or fiction? J. Gastroenterol. Hepatol 30:14–20
Article
CAS
PubMed
Google Scholar
Liu J, Yang HI, Lee MH et al (2010) Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterol 139:474–482
Article
Google Scholar
Kang SK, Chung TW, Lee JY, Lee et al (2004) The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. J biol chem 279:28106–28112
Chiang CH, Yang HI, Jen CL et al (2013) Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int j Obes 37:410–415
Article
Google Scholar
Su TC, Lee YT, Cheng TJ et al (2004) Chronic hepatitis B virus infection and dyslipidemia. J Formos Med Assoc 103:286–291
PubMed
Google Scholar
Chen JY, Wang JH, Lin CY et al (2010) Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B, C strains independently. J. Gastroenterol. Hepatol 25:1763–1768
Article
PubMed
Google Scholar
Wong VW, Wong GL, Yu J et al (2010) Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. Am. J. Gastroenterol. Suppl 105:132–138
Article
CAS
Google Scholar
Hui CK, Zhang HY, Lee NP et al (2007) Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. Hepatol 47:191–202
Article
CAS
Google Scholar
Ramcharran D, Wahed AS, Conjeevaram HS et al (2010) Associations between serum lipids and hepatitis C antiviral treatment efficacy. Hepatol 52:854–863
Article
CAS
Google Scholar
Wong VW, Wong GL, Chu WC et al (2012) Hepatitis B virus infection and fatty liver in the general population. Hepatol 56:533–540
Article
Google Scholar
Johnson NA, Walton DW, Sachinwalla T et al (2008) Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatol 47:1513–1523
Article
CAS
Google Scholar
Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R et al (2007) Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population-based study. Hepatol 47:711–717
Article
CAS
Google Scholar
Hallsworth K, Fattakhova G, Hollingsworth KG et al (2011) Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60:1278–1283
Article
PubMed
Google Scholar
Hou XH, Zhu YX, Lu HJ et al (2011) Non-alcoholic fatty liver disease’s prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. J. Gastroenterol. Hepatol 26:722–730
Article
CAS
PubMed
Google Scholar
Hsu CS, Liu CH, Wang CC et al (2012) Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepatitis 19:e48–e57
Article
Google Scholar
Lee IC, Huang YH, Chan CC et al (2011) Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B. Clin Nutri 30:647–652
Article
CAS
Google Scholar
Na TY, Shin YK, Roh KJ et al (2009) Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus associated hepatocellular carcinoma. Hepatol 49:1122–1131
Article
CAS
Google Scholar
Jan CF, Chen CJ, Chiu YH et al (2006) A population based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Intern j Obes 30:794–799
Article
Google Scholar
Peng D, Han Y, Ding H et al (2008) Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J. Gastroenterol. Hepatol 23:1082–1088
Article
CAS
PubMed
Google Scholar
Shi JP, Fan JG, Wu R et al (2008) Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J. Gastroenterol. Hepatol 23:1419–1425
Article
PubMed
Google Scholar
Shi JP, Fan JG, Wu R et al (2008) Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol. 2008;23(9):1419-25. https://doi.org/10.1111/j.1440-1746.2008.05531.x. PMID: 18853998.
Fan JG, Farrell GC (2009) Epidemiology of non-alcoholic fatty liver disease in China. Hepatol 50:204–210
Article
Google Scholar
Wang CC, Hsu CS, Liu CJ et al (2008) Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J. Gastroenterol. Hepatol 23:779–782
Article
PubMed
CAS
Google Scholar
Wong GL, Wong VW, Choi PC et al (2009) Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 58(1):111–117
Article
PubMed
Google Scholar
Rastogi A, Sakhuja P, Kumar A et al (2011) Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Micr 54(3):454–9.4
Article
Google Scholar
Fan JG, Jia JD, Li YM et al (2011) Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166). J Dig Dis 12(1):38–44
Article
PubMed
Google Scholar
Yun JW, Chom YK, Parkm JH et al (2009) Hepatic steatosis and fibrosis in young men with treatment-naive chronic hepatitis B. Liver Int 29(6):878–883
Article
CAS
PubMed
Google Scholar
Paik YH, Schwabe RF, Bataller R et al (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatol 37(5):1043–1055
Article
CAS
Google Scholar
Michelsen KS, Wong MH, Shah PK et al (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. PNAS 101(29):10679–10684
Spruss A, Kanuri G, Wagnerberger S et al (2009) Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatol 50(4):1094–1104
Article
CAS
Google Scholar
Rivera CA, Adegboyega P, Van Rooijen N et al (2007) Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. Hepatol 47(4):571–579
Article
CAS
Google Scholar
Yang L, Seki E (2012) Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front Physiol 3:138
CAS
PubMed
PubMed Central
Google Scholar
Lee JY, Sohn KH, Rhee SH et al (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. Biol Chem 276(20):16683–16689
Chen Z, Cheng Y, Xu Y et al (2008) Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. J. Clin Immunol 128(3):400–408
Article
CAS
Google Scholar
Wu J, Lu M, Meng Z et al (2007) Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatol 46(6):1769–1778
Article
CAS
Google Scholar
Sweet MJ, Hume DA (1996) Endotoxin signal transduction in macrophages. J. Leukoc. Biol 60(1):8–26.21
Article
CAS
PubMed
Google Scholar
Wang MM, Wang GS, Shen F et al (2014) Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors. Digest Dis Sci 59:2571–2579
Chu CM, Lin DY, Liaw YF (2013) Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without. Digest Dis Sci 58:275–281
Article
CAS
PubMed
Google Scholar
Chu CM, Lin DY, Liaw YF (2007) Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection? Int J of Obes 31:871–875
Article
Google Scholar
Feldstein AE, Canbay A, Angulo P et al (2003) Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterol 125:437–443
Article
Google Scholar
Brown AJ (2008) Viral hepatitis and fatty liver disease: how an unwelcome guest makes pâté of the host. Biochem 416:e15–e17
Article
CAS
Google Scholar
Hajjou M, Norel R, Carver R et al (2005) cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J Med Virol 77:57–65
Article
CAS
PubMed
Google Scholar
Jiang CY, Zeng WQ, Chen YX et al (2011) Effect of HBV on the expression of SREBP in the hepatocyte of chronic hepatitis B patients combined with hepatic fatty change. Zhonghua Gan Zang Bing Za Zhi 19:608–613
CAS
PubMed
Google Scholar
Jin X, Chen Y, Yang Y et al (2012) Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B. PloS One 7:e34198
Article
CAS
PubMed
PubMed Central
Google Scholar
Taliani G, Duca F, Lecce R et al (1995) Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis. Hepatol 21:1760–1761
Article
CAS
Google Scholar
Leclercq I, Horsmans Y, Desager JP et al (1998) Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation. Hepatol 28:410–416
Article
CAS
Google Scholar
Poortahmasebi V, Alavian SM, Keyvani H et al (2014) Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. Asian Pac J Cancer P 15:3879–3884
Ceylan B, Arslan F, Batırel A et al (2016) Impact of fatty liver on hepatitis B virüs replication and virolojik response to tenofovir and entecavir. Turk J of Gastroenterol 27:42–46
Article
Google Scholar
Jarosz M, Respondek W, Grzymisławski M (2010) Dietary recommendations and lifestyle [Polish]. In: Jarosz M (ed) Nonalcoholic fatty liver disease. PZWL, Warsaw, pp 45–56
Google Scholar
Sauberlich HE (2007) Nutrition of human with elements of biochemistry [Polish]. In: Ciborowska H, Rudnicka A (eds) Dietetics. Nutritional therapy for healthy and ill patients. PZWL, Warsaw, pp 280–289
Google Scholar
Zivkovic AM, German JB, Sanyal AJ (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86:285–300
Article
CAS
PubMed
Google Scholar
York LW, Puthalapattu S, Wu GY (2009) Nonalcocholic fatty liver disease and low-carbohydrate diets. Annu Rev Nutr 29:365–379
Article
CAS
PubMed
Google Scholar
Cani PD, Knauf C, Iglesias MA et al (2006) Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. J. Diabetes 55:1484
Article
CAS
Google Scholar
Yu S, Zhang G, Jin LH (2018) A high-sugar diet affects cellular and humeral immune responses in Drosophila. Exp Cell Res 368(2):215–224
Article
CAS
PubMed
Google Scholar
Bae YS, Shin EC, Bae YS et al (2019) Editorial: Stress and Immunity. Front Immunol 10:245
Article
CAS
PubMed
PubMed Central
Google Scholar
Ott JJ, Stevens GA, Groeger J et al (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30:2212–2219